Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Hologic Inc HOLX

Hologic, Inc. is a medical technology company primarily focused on improving women's health and well-being through early detection and treatment. The Company is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products. It operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The Diagnostics segment... see more

Recent & Breaking News (NDAQ:HOLX)

Hologic to Webcast Presentation at the 39th Annual J.P. Morgan Healthcare Conference

Business Wire December 28, 2020

Hologic Receives FDA Clearance for Latest Breakthrough in Early Breast Cancer Detection, Genius AI(TM) Detection

Business Wire December 1, 2020

Hologic to Showcase Products Across Breast Cancer Screening, Biopsy, Surgery and Treatment at Virtual RSNA 2020

Business Wire November 27, 2020

Hologic to Webcast Presentation at Upcoming Virtual Investor Conference

Business Wire November 25, 2020

Aptima HIV-1 Quant Dx Assay Receives Additional FDA Approval for Use as an Aid in the Diagnosis of HIV Infection

Business Wire November 20, 2020

Hologic Announces Financial Results for Fourth Quarter of Fiscal 2020

Business Wire November 4, 2020

Hologic Awarded U.S. Government Contract to Expand COVID-19 Test Production Capacity

Business Wire October 30, 2020

Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2020 on Wednesday, November 4, 2020

Business Wire October 7, 2020

FDA Amends Emergency Use Authorization for Hologic's Aptima SARS-CoV-2 Assay to Include COVID-19 Testing of Asymptomatic Individuals, Symptomatic Sample Pooling

Business Wire October 6, 2020

Hologic Announces Multi-Year, Multi-Pronged Commitment to Tackling Breast Cancer Screening Disparities for Black Women in Partnership with the Black Women's Health Imperative and RAD-AID

Business Wire October 1, 2020

Hologic Granted FDA Emergency Use Authorization for Asymptomatic COVID-19 Testing with Panther Fusion SARS-CoV-2 Assay

Business Wire September 28, 2020

Hologic Announces Pricing of Offering of $950 Million of 3.250% Senior Notes Due 2029

Business Wire September 14, 2020

Hologic Announces Offering of $950 Million of Senior Notes Due 2029

Business Wire September 14, 2020

Hologic to Webcast Presentations at Upcoming Investor Conferences

Business Wire September 4, 2020

Hologic to Acquire Acessa Health, Innovator in Minimally Invasive Solutions for Treatment of Fibroids

Business Wire August 25, 2020

Hologic Launches Validated Pooling Protocol for COVID-19 Testing

Business Wire August 11, 2020

Hologic Announces 'Back to Screening' Campaign Encouraging Women to Prioritize Mammograms Delayed due to COVID-19 Pandemic

Business Wire August 3, 2020

New Cervical Cancer Screening Guidelines from the American Cancer Society Risk Reversing Decades of Progress Made Against Cervical Cancer

Business Wire July 31, 2020

Hologic Announces Financial Results for Third Quarter of Fiscal 2020

Business Wire July 29, 2020

Hologic Launches its First Cart-Based Ultrasound System, SuperSonic(TM) MACH 40

Business Wire July 8, 2020